Jump Financial LLC grew its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 549.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 48,163 shares of the insurance provider's stock after buying an additional 40,747 shares during the period. Jump Financial LLC's holdings in Humana were worth $12,744,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of the business. Cary Street Partners Investment Advisory LLC grew its holdings in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after buying an additional 46 shares during the last quarter. Applied Finance Capital Management LLC boosted its holdings in shares of Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after purchasing an additional 48 shares during the last quarter. Achmea Investment Management B.V. boosted its holdings in shares of Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after purchasing an additional 49 shares during the last quarter. Beech Hill Advisors Inc. boosted its holdings in shares of Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after purchasing an additional 50 shares during the last quarter. Finally, Townsquare Capital LLC boosted its holdings in shares of Humana by 2.8% during the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after purchasing an additional 61 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Humana Stock Up 0.2%
NYSE:HUM traded up $0.73 during mid-day trading on Thursday, reaching $297.99. The stock had a trading volume of 995,348 shares, compared to its average volume of 1,708,251. The company has a market capitalization of $35.84 billion, a price-to-earnings ratio of 22.87, a price-to-earnings-growth ratio of 1.76 and a beta of 0.44. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $382.72. The stock's 50 day simple moving average is $252.05 and its two-hundred day simple moving average is $254.08. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.
Humana Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana's payout ratio is currently 27.17%.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on HUM shares. Morgan Stanley decreased their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Royal Bank Of Canada increased their target price on Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research report on Thursday, August 21st. Robert W. Baird cut their price objective on Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Bank of America cut their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Finally, Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $283.29.
Check Out Our Latest Stock Analysis on Humana
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.